Regular treatment of asthma in adults where use of a combination product (inhaled corticosteroid & long-acting β
2-agonist) is appropriate; patients not adequately controlled w/ inhaled corticosteroids & as needed inhaled short-acting β
2-agonist or patients already adequately controlled on both inhaled corticosteroids & long-acting β
2-agonists.